Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ada-Maria Minutello"'
Autor:
Sylvie Pichon, Francoise Guinet-Morlot, Jamshid Saleh, Brandon Essink, Andrea-Clemencia Pineda-Peña, Annick Moureau, Celine Petit, Ada-Maria Minutello
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 3 (2023)
ABSTRACTA serum-free, highly purified rabies vaccine produced in Vero cells is under development. The initial formulation, PVRV-NG, was evaluated in five Phase II studies and subsequently reformulated (PVRV-NG2). This multicenter, observer-blinded Ph
Externí odkaz:
https://doaj.org/article/3be5e7b2218741b89b1c7f131c965a9a
Autor:
Beatriz Quiambao, Cecilia Montalban, Ada-Maria Minutello, Françoise Guinet-Morlot, Annick Moureau, Celine Petit, Sylvie Pichon
Publikováno v:
Vaccine. 40(35)
A serum-free, highly purified Vero rabies vaccine (PVRV-NG) has been developed with no animal or human components and low residual DNA content. A phaseII randomized clinical study aimed to demonstrate the non-inferiority of the immune response and as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5c6b5b4cf96fa83883b80824a710f5b
https://pubmed.ncbi.nlm.nih.gov/35906106
https://pubmed.ncbi.nlm.nih.gov/35906106
Autor:
Sylvie Pichon, Annick Moureau, Celine Petit, L. Chu, B. Essink, D. Muse, J. Saleh, Françoise Guinet-Morlot, Ada-Maria Minutello
Publikováno v:
Vaccine. 40(33)
A serum-free, highly purified Vero cell rabies vaccine (PVRV-NG) is under development. We previously demonstrated that pre-exposure prophylaxis (PrEP) with PVRV-NG had a satisfactory safety profile and was immunogenically non-inferior to the licensed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dad7bd2046d9c974f2569623abc52b26
https://pubmed.ncbi.nlm.nih.gov/35778281
https://pubmed.ncbi.nlm.nih.gov/35778281